2025 annual financial data
Estrella Immunopharma 2025 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -13,062,674 USD and net income was -13,063,512 USD.
Operating cash flow was -1,785,679 USD.
Get free Estrella Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,062,674 USD
- Net income
- -13,063,512 USD
- Operating cash flow
- -1,785,679 USD